Primary feasibility analysis of neoadjuvant chemotherapy with bevacizumab for resectable stage II/IIIA non-squamous non-small cell lung cancer: the NAVAL phase II study.
N. Tsubokawa
Yasuhiro Tsutani
Y. Miyata
Kenji Suzuki
K. Takamochi
F. Tanaka
Hiroyuki Ito
Y. Yamashita
M. Oda
T. Mimae
Morihito Okada
Medicine